المؤلفون: Meijer, AJM, Diepstraten, FA, Ansari, M, Bouffet, E, Bleyer, A, Fresneau, B, Geller, JI, Huitema, ADR, Kogner, P, Maibach, R, O'Neill, AF, Papadakis, V, Rajput, KM, Veal, GJ, Sullivan, M, van den Heuvel-eibrink, MM, Brock, PR

المصدر: Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 42(18):2219-2232

مصطلحات موضوعية: Medicin och hälsovetenskap

URL الوصول: http://kipublications.ki.se/Default.aspx?queryparsed=id:158601276

المؤلفون: Clemens, Eva, Van den Heuvel - Eibrink, Marry, Mulder, RL, Kremer, LCM (Leontien), Hudson, MM, Skinner, R, Constine, LS, Bass, JK, Kuehni, CE, Langer, T, van Dalen, EC, Bardi, E, Bonne, NX, Brock, PR, Brooks, B, Carleton, B, Caron, E, Chang, KW, Johnston, K, Knight, K, Nathan, PC, Orgel, E, Prasad, PK, Rottenberg, J, Scheinemann, K, de Vries, A.C.H., Walwyn, T, Weiss, A, Zehnhoff-Dinnesen, AA, Cohn, RJ, Landier, W, Kadan-Lottick, N, Levitt, G, Hoetink, A, Mussman, J

المساهمون: Princess Máxima Center for Pediatric Oncology [Utrecht, Netherlands], Erasmus MC-Sophia Hospital [Rotterdam, Netherlands], Emma Children's Hospital [Amsterdam, Netherlands] (Academic Medical Center), University of Amsterdam [Amsterdam] (UvA), St Jude Children's Research Hospital, Great North Children’s Hospital [Newcastle Upon Tyne, UK], Northern Institute for Cancer Research [Newcastle] (NICR), Newcastle University [Newcastle], University of Rochester Medical Center (URMC), Institute of Social and Preventive Medicine [Bern] (ISPM), Universität Bern [Bern] (UNIBE), University Hospital for Children and Adolescents [Lübeck, Germany], Protéomique, Réponse Inflammatoire, Spectrométrie de Masse (PRISM) - U 1192 (PRISM), Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lille-Centre Hospitalier Régional Universitaire [Lille] (CHRU Lille), Service d'Otologie et d'Otoneurologie [CHU Lille], Centre Hospitalier Universitaire de Lille (CHU de Lille), Great Ormond Street Hospital for Children NHS Foundation Trust [London, UK] (GOSHC), University of British Columbia (UBC), Stanford University, Sydney Children's hospital, Oregon Health and Science University [Portland] (OHSU), The Hospital for sick children [Toronto] (SickKids), Children’s Hospital Los Angeles [Los Angeles], University of Southern California (USC), Louisiana State University (LSU), Children's Hospital at New Orleans, Masaryk University [Brno] (MUNI), Kantonsspital Aarau [Aarau, Switzerland], University Hospital Basel [Basel], McMaster University [Hamilton, Ontario], Perth Children's Hospital [Nedlands, WA, Australia], The University of Western Australia (UWA), University of Regensburg, University Hospital Münster - Universitaetsklinikum Muenster [Germany] (UKM), University of New South Wales [Sydney] (UNSW), University of Alabama at Birmingham [ Birmingham] (UAB), SALZET, Michel, Pediatrics, Universität Bern [Bern], Université de Lille-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre Hospitalier Régional Universitaire [Lille] (CHRU Lille), Great Ormond Street Hospital for Children NHS Foundation Trust [London, UK]

المصدر: Lancet Oncology
Lancet Oncology, 2019, 20 (1), pp.e29-e41. ⟨10.1016/S1470-2045(18)30858-1⟩
Lancet Oncol
Lancet Oncology, 20(1), E29-E41. Lancet Publishing Group
The Lancet Oncology
The Lancet Oncology, 2019, 20 (1), pp.e29-e41. ⟨10.1016/S1470-2045(18)30858-1⟩

مصطلحات موضوعية: Shunt placement, Pediatrics, medicine.medical_specialty, Adolescent, [SDV]Life Sciences [q-bio], Childhood cancer, Harmonization, Antineoplastic Agents, Platinum Compounds, Article, 03 medical and health sciences, Young Adult, 0302 clinical medicine, Ototoxicity, SDG 3 - Good Health and Well-being, Cancer Survivors, Neoplasms, otorhinolaryngologic diseases, Medicine, Humans, Young adult, 030223 otorhinolaryngology, Child, Evidence-Based Medicine, business.industry, Cancer, Guideline, medicine.disease, 3. Good health, [SDV] Life Sciences [q-bio], Oncology, 030220 oncology & carcinogenesis, Population Surveillance, Cranial Irradiation, business, Delivery of Health Care

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::52c9691c172f35b13ef8adca102c2338
https://www.hal.inserm.fr/inserm-02941725

المؤلفون: Brock PR, Maibach R, Childs M, Rajput K, Roebuk D, Sullivan MJ, Laithier V, Ronghe M, Dall'Igna P, Hiyama E, Brichard B

المساهمون: UCL - SSS/IREC/PEDI - Pôle de Pédiatrie, UCL - (SLuc) Service d'hématologie et d'oncologie pédiatrique

المصدر: N Engl J Med, Vol. 25, no.378, p. 2376-2385 (2018)

مصطلحات موضوعية: otorhinolaryngologic diseases

URL الوصول: https://explore.openaire.eu/search/publication?articleId=od______1493::de0442e557cca78f69ddf2ed6a9d88dc
https://hdl.handle.net/2078.1/213039

المؤلفون: Burchill, SA, Beiske, K, Shimada, H, Ambros, PF, Seeger, R, Tytgat, GAM, Brock, PR, Haber, M, Park, JR, Berthold, F

وصف الملف: application/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=core_ac_uk__::4da1f7aba72b76c40bc70122bf0affa5

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

المؤلفون: Brock PR; Oncology Department, Great Ormond Street Hospital for Children, NHS Foundation Trust, London, United Kingdom.

المصدر: Cancer [Cancer] 2022 Jan 01; Vol. 128 (1), pp. 43-46. Date of Electronic Publication: 2021 Sep 07.

نوع المنشور: Editorial; Comment

بيانات الدورية: Publisher: Wiley Country of Publication: United States NLM ID: 0374236 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-0142 (Electronic) Linking ISSN: 0008543X NLM ISO Abbreviation: Cancer Subsets: MEDLINE

مواضيع طبية MeSH: Antineoplastic Agents*/administration & dosage , Antineoplastic Agents*/adverse effects , Hearing Loss*/chemically induced , Hearing Loss*/diagnosis , Ototoxicity*, Carboplatin/administration & dosage ; Child ; Child, Preschool ; Cisplatin/administration & dosage ; Cisplatin/adverse effects ; Humans

المؤلفون: Meijer AJM; Department of Pediatric Oncology, Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., van den Heuvel-Eibrink MM; Department of Pediatric Oncology, Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.; Department of Pediatric Oncology, Erasmus Medical Center-Sophia Children's Hospital, Rotterdam, the Netherlands., Brooks B; Department of Audiology and Speech Pathology, BC Children's Hospital, Vancouver, British Columbia, Canada.; School of Audiology and Speech Science, University of British Columbia, Vancouver, British Columbia, Canada., Am Zehnhoff-Dinnesen AG; Department of Phoniatrics and Pedaudiology, University Hospital Muenster, Westphalian Wilhelm University, Muenster, Germany., Knight KR; Department of Pediatric Audiology, Oregon Health and Science University, Portland., Freyer DR; Cancer and Blood Disease Institute, Children's Hospital Los Angeles, Los Angeles, California.; Department of Pediatrics, Keck School of Medicine, University of Southern California, Los Angeles.; Department of Medicine, Keck School of Medicine, University of Southern California, Los Angeles.; Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles., Chang KW; Department of Otolaryngology, Stanford University School of Medicine, Palo Alto, California., Hero B; Department of Pediatric Hematology-Oncology, Children's Hospital, University of Cologne, Cologne, Germany., Papadakis V; Department of Pediatric Hematology-Oncology, Agia Sofia Children's Hospital, Athens, Greece., Frazier AL; Dana Farber/Boston Children's Cancer and Blood Disorders Center, Harvard Medical School, Boston, Massachusetts., Blattmann C; Department of Pediatric Oncology/Hematology/Immunology, Stuttgart Cancer Center, Olgahospital Stuttgart, Stuttgart, Germany., Windsor R; Department of Oncology, University College London Hospitals National Health Service Trust, London, United Kingdom., Morland B; Department of Pediatric Oncology, Birmingham Children's Hospital, Birmingham, United Kingdom., Bouffet E; Division of Haematology/Oncology, The Hospital for Sick Children, Toronto, Ontario, Canada., Rutkowski S; Department of Pediatric Hematology and Oncology, University Medical Center Hamburg, Hamburg, Germany., Tytgat GAM; Department of Pediatric Oncology, Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., Geller JI; Division of Oncology, Cincinnati Children's Hospital Medical Center, University of Cincinnati, Cincinnati, Ohio., Hunter LL; Communication Sciences Research Center, Cincinnati Children's Hospital Medical Center, University of Cincinnati, Cincinnati, Ohio., Sung L; Division of Haematology/Oncology, The Hospital for Sick Children, Toronto, Ontario, Canada.; Program in Child Health Evaluative Sciences, The Hospital for Sick Children, Peter Gilgan Centre for Research and Learning, Toronto, Canada., Calaminus G; Department of Pediatric Hematology and Oncology, University Hospital Bonn, Bonn, Germany., Carleton BC; BC Children's Hospital Research Institute, Vancouver, British Columbia, Canada.; Division of Translational Therapeutics, Department of Pediatrics, Faculty of Medicine, University of British Columbia, Vancouver, British Columbia, Canada.; Pharmaceutical Outcomes Programme, BC Children's Hospital, Vancouver, British Columbia, Canada., Helleman HW; Department of Otorhinolaryngology, Head and Neck Surgery, University Medical Center Utrecht-Wilhelmina Children's Hospital, Utrecht, the Netherlands., Foster JH; Department of Pediatrics, Section of Hematology-Oncology, Texas Children's Cancer and Hematology Centers, Houston, Texas., Kruger M; Department of Pediatrics and Child Health, Faculty of Medicine and Health Sciences, Stellenbosch University and Tygerberg Hospital, Cape Town, South Africa., Cohn RJ; Kids Cancer Centre, Sydney Children's Hospital, High Street, Randwick, Australia.; School of Women's and Children's Health, University of New South Wales Medicine, Sydney, Australia., Landier W; Department of Pediatrics, Institute for Cancer Outcomes and Survivorship, School of Medicine, University of Alabama at Birmingham., van Grotel M; Department of Pediatric Oncology, Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., Brock PR; Department of Pediatric Oncology, Great Ormond Street Hospital for Children National Health Service Trust, London, United Kingdom., Hoetink AE; Department of Otorhinolaryngology, Head and Neck Surgery, University Medical Center Utrecht-Wilhelmina Children's Hospital, Utrecht, the Netherlands., Rajput KM; Department of Audiovestibular Medicine and Cochlear Implant, Great Ormond Street Hospital for Children National Health Service Trust, London, United Kingdom.

مؤلفون مشاركون: Society of Paediatric Oncology Supportive Care Committee

المصدر: JAMA oncology [JAMA Oncol] 2021 Oct 01; Vol. 7 (10), pp. 1550-1558.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: American Medical Association Country of Publication: United States NLM ID: 101652861 Publication Model: Print Cited Medium: Internet ISSN: 2374-2445 (Electronic) Linking ISSN: 23742437 NLM ISO Abbreviation: JAMA Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Hearing Loss*/chemically induced , Hearing Loss*/diagnosis , Neoplasms*/drug therapy, Child ; Cisplatin/therapeutic use ; Cranial Irradiation ; Humans ; Medical Oncology